Gastroenterology & Hepatology Advanced Practice Providers (GHAPP)

GHAPPcast

Health EN ↓ 170 episodes

This is the official podcast of The Gastroenterology & Hepatology Advanced Practice Providers (GHAPP), an association is dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs).   Through our peer-to-peer network, we seek to support their integral role in the specialty healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with gastrointestinal (GI) disorders and chronic liver disease (CLD).

Be sure to visit the podcast's website and support the creator: ghappcast.captivate.fm

Author

Gastroenterology & Hepatology Advanced Practice Providers (GHAPP)

Category

Health

Podcast website

ghappcast.captivate.fm

Latest episode

Nov 17, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

FAQ: What does it mean for a biosimilar to be interchangeable and why is that important? 17.09.2024

Thank you to Boehringer Ingelheim for your support of this FAQ Video Module. Join Tedra Gray, NP, as she dives into what it means for a biosimilar to be interchangeable. Interchangeability is a key designation in the world of biosimilars, ensuring that these medications can be substituted for their reference products at the pharmacy level without the need for prescriber approval. Only a select few...

GHAPPcast: Navigating IBS: Pathophysiology, Neuromodulators, and Patient-Centered Care 17.09.2024

Thank you to Ardelyx for your support of this GHAPPcast episode. In this episode of GHAPPcast, the official podcast for Gastroenterology and Hepatology Advanced Practice Providers, host Christina Hanson, NP, is joined by Kim Kearns, NP, to explore the complex pathophysiology of IBS-C (Irritable Bowel Syndrome with Constipation) and the evolving neuromodulation strategies that enhance patient care....

GHAPPcast: Biosimilars and the Patient Perspective 17.09.2024

Thank you to Boehringer Ingelheim for your support of this podcast. Welcome to GHAPPcast, the official podcast for gastroenterology and hepatology advanced practice providers. Hosted by Gabriella McCarty, a nurse practitioner at NorthShore Gastroenterology in Cleveland, this episode dives into a crucial topic—biosimilars from a patient’s perspective. As a founding member of GHAPP and a provider wi...

GHAPPcast: Mastering IBS-C: Diagnostic Strategies, Differentiation, and Management. 10.09.2024

Thank you to Ardelyx for sponsoring this GHAPPcast episode!  In this episode of GHAPPcast, host Christina Hanson, FNP, alongside guest Kim Orleck, PA-C, dives into advanced strategies for diagnosing and managing IBS-C. They discuss the importance of the positive diagnostic strategy, ways to differentiate IBS-C from other conditions, and share valuable insights on how to optimize patient care...

FAQ: What is the Difference Between Biosimilars and Generics? 04.09.2024

Thank you to Boehringer Ingelheim for your support of this FAQ Video Module. Join Tedra Gray, NP, as she explains how biosimilars and generics play a crucial role in modern medicine, especially in fields like gastroenterology, rheumatology, and dermatology. She explains the key differences between biosimilars and generic medications, helping both healthcare providers and patients make informed tre...

FAQ: What Role Does a New Mechanism of Action Play in Your Prescribing Decisions of IBS-C Therapy? 26.08.2024

Thank you to Ardelyx for your support of this FAQ Video Module. For years, the primary treatment options for irritable bowel syndrome with constipation (IBS-C) have been limited to secretagogues, offering varying doses and tolerability. However, a new mechanism of action (MOA) is now available, revolutionizing treatment choices for healthcare providers and patients alike. In this discussion, Kim O...

GHAPPcast: Biosimilars Unveiled: Empowering APPs for Better Patient Conversations 21.08.2024

Thank you to Boehringer Ingelheim for your support of this podcast. In this episode of GHAPPcast, the official podcast for Gastroenterology and Hepatology Advanced Practice Providers, host Gabriella McCarty, NP, is joined by Tedra Gray, NP, to explore the role of biosimilars in GI treatment. They dive into the differences between biosimilars and generics, the cost savings associated with biosimila...

CLDF/GHAPP Roundtable Podcast Series: MASH with Nadege Gunn, MD, Elizabeth Goacher, PA, and Ann Moore, FNP 05.08.2024

Join Dr. Nadege Gunn, from the 2024 Liver Connect Conference. In this special episode, she is joined by Elizabeth Coacher, PA, and Ann Moore, FNP, to discuss the management of NASH (Nonalcoholic Steatohepatitis), newly approved treatments, and the importance of clinical trials. They explore patient-centered care, lifestyle modifications, and non-invasive tests for identifying at-risk patients. Tun...

Discussing Biosimilars With Patients 13.12.2023

In our twelfth and final episode of the GHAPP & RhAPP biosimilar podcast series host Gabriella McCarty, NP, and guest Jamie Brogan, NP have an in-depth conversation about discussing biosimilars with patients. The learning objectives for this episode are to: Design methods to appropriately explain biosimilars to patients Address potential patient perceptions of biosimilars Devise methods to com...

The Nocebo Effect 08.12.2023

Welcome to our eleventh episode of the GHAPP & RhAPP biosimilar podcast series! In the penultimate episode host Amanda Mixon, PA-C has an in-depth conversation with the incredible Naomi A. Amudala, CRNP, MSN,  about The Nocebo Effect. The learning objectives and goals for this episode are to: Define the nocebo effect Appraise nocebo effect research as it pertains to biosimilars Explain effecti...

The Practical Use of Biosimilars in Gastroenterology APP Practice 08.11.2023

In the tenth episode of the GHAPP & RhAPP biosimilar podcast series host Gabriella McCarty, NP-C, and guest Sharon Dudley-Brown PHD, FNP-BC, FAAN, FAANP discuss the practical use of biosimilars in Gastroenterology APP practice. The learning objectives for this episode are to: Interpret the AGA Biosimilars Roundtable meeting report and the Crohn’s & Colitis Foundation Biosimilar position st...

The Practical Use of Biosimilars in Rheumatology APP Practice 30.10.2023

In the ninth episode of the GHAPP & RhAPP biosimilar podcast series host Amanda Mixon, PA-C, and guest Daric Mueller, PA-C discuss the practical use of biosimilars in rheumatology APP practice. The learning objectives for this episode are to: Interpret the ACR white paper on biosimilars in rheumatology Discuss the use of biosimilars in the treatment of rheumatic diseases Produce strategies for...

The Benefits of Biosimilars 11.10.2023

In our eighth episode of the GHAPP & RhAPP biosimilar podcast series host Gabriella McCarty, NP, and guest Gwen Cassidy, NP review the benefits of biosimilars. The learning objectives for this episode are to: Outline the cost savings of biosimilars for patients Summarize the cost savings for healthcare organizations Discuss  healthcare providers  feeling the pressure and burden of rising costs...

Managed Care and Biosimilars 03.10.2023

In the seventh episode of the GHAPP & RhAPP biosimilar podcast series host Amanda Mixon, PA-C, and guest Audrey Gibson, PA-C discuss the interplay between managed care and biosimilars. The learning objectives for this episode are to: Discuss managed care implications for biosimilars reaching the market Identify the benefits of biosimilars in managed care Formulate strategies managed care profe...

Interchangeability & Switching of Biosimilars 15.09.2023

For our sixth episode of the GHAPP & RhAPP biosimilar podcast series host Gabriella McCarty, NP-C, and guest Janette Villalon, NP discuss interchangeability & switching of biosimilars. The learning objectives and goals for this episode are to: -Define interchangeability -Illustrate the required info for a biosimilar to be deemed interchangeable by the FDA -Recognize how interchangeability...

Biosimilar Extrapolation 23.08.2023

In the fifth episode of the GHAPP & RhAPP biosimilar podcast series host Amanda Mixon, PA-C, and guest Betsy Kirchner, DNP review the important concept of biosimilar extrapolation. The learning objectives for this episode are to: Define extrapolation Understand why extrapolation is important. Understand the key aspects that may be considered for scientific justification of extrapolation includ...

The Difference Between Biosimilars & Generic Drugs 08.08.2023

In the fourth episode of the GHAPP & RhAPP biosimilar podcast series host Gabriella McCarty, NP  and guest Tedra Gray, NP discuss the differences between biosimilars and generic drugs. The learning objectives and goals for this episode are to: -Compare and contrast biosimilars and generics regarding:          -Molecular size and structure          -Complexity of development          -Cost of d...

The Regulatory Pathway to Biosimilar Approval 25.07.2023

Welcome to our third episode of the GHAPP & RhAPP biosimilar podcast series! In this episode host Amanda Mixon, PA-C has an in-depth conversation with the incredible Danielle Gatti-Palumbo, PharmD, BCACP, AAHIVP,  about The Regulatory Pathway to Biosimilar Approval. The learning objectives and goals for this episode are to: -Summarize the totality of evidence approach to determining biosimilar...

Development of Biosimilars 13.07.2023

Join us for our second episode of the GHAPP & RhAPP biosimilar podcast series! In this episode host Amanda Mixon, PA-C discusses the Development of Biosimilars with our esteemed guest Tanya Golovanoff, PharmD. The learning objectives and goals for this episode are to: -Distill the immense amount of research and development that occurs to develop biosimilars -Articulate the biosimilar manufactu...

Biosimilars Series: What Are Biosimilars? 14.06.2023

Join us for the first episode of the GHAPP & RhAPP biosimilar podcast series! In this episode Gabriella McCarty, NP-C and Jennifer Geremia, PA-C discuss What Are Biosimilars? The learning objectives and goals for this episode are to: -Define biologic therapy -Define biosimilars -Define reference product -Summarize the impact of The Biologics Price Competition and Innovation Act Please take our...

Listen to the GHAPPcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.